Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$558M |
| 2 |
Apple
AAPL
|
+$265M |
| 3 |
Microsoft
MSFT
|
+$209M |
| 4 |
Amazon
AMZN
|
+$197M |
| 5 |
Visa
V
|
+$180M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$86.3M |
| 2 |
TSMC
TSM
|
+$77.2M |
| 3 |
iShares MBS ETF
MBB
|
+$44.5M |
| 4 |
KSU
Kansas City Southern
KSU
|
+$43.8M |
| 5 |
Vale
VALE
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.97% |
| 2 | Financials | 12.67% |
| 3 | Consumer Discretionary | 11.32% |
| 4 | Healthcare | 10.27% |
| 5 | Communication Services | 7.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
26
Novo Nordisk
NVO
$228B
| $1.35B | 0.85% |
32,163,974
+54,584
| +0.2% | +$2.12M |
|
27
SAP
SAP
$209B
| $1.25B | 0.78% |
8,864,440
+272,099
| +3% | +$37.9M |
|
28
Intuitive Surgical
ISRG
$126B
| $1.21B | 0.76% |
3,963,150
+138,906
| +4% | +$39M |
|
29
Cisco
CSCO
$448B
| $1.18B | 0.74% |
22,290,297
+802,861
| +4% | +$42.2M |
|
30
Nike
NKE
$62.7B
| $1.17B | 0.73% |
7,569,406
+272,560
| +4% | +$36.7M |
|
31
Oracle
ORCL
$367B
| $1.16B | 0.73% |
14,881,574
+539,617
| +4% | +$42.2M |
|
32
UnitedHealth
UNH
$383B
| $1.14B | 0.71% |
2,837,053
+138,408
| +5% | +$55.2M |
|
33
AstraZeneca
AZN
$266B
| $1.13B | 0.71% |
9,415,247
+220,903
| +2% | +$24.2M |
|
34
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
| $1.12B | 0.71% |
9,734,282
+932,848
| +11% | +$107M |
|
35
Rio Tinto
RIO
$158B
| $1.08B | 0.68% |
12,926,059
+409,383
| +3% | +$35.2M |
|
36
JPMorgan Chase
JPM
$933B
| $1.07B | 0.67% |
6,904,377
+212,570
| +3% | +$33.4M |
|
37
3M
MMM
$90.8B
| $1.07B | 0.67% |
6,449,935
+317,510
| +5% | +$53M |
|
|
SI
38
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
| $1.07B | 0.67% |
13,460,724
-262,818
| -2% | -$20.8M |
|
39
TotalEnergies
TTE
$193B
| $1.05B | 0.66% |
23,170,344
+883,088
| +4% | +$41.3M |
|
40
NextEra Energy
NEE
$183B
| $1.04B | 0.65% |
14,153,018
+546,944
| +4% | +$41M |
|
41
Goldman Sachs
GS
$302B
| $1.03B | 0.65% |
2,713,876
+130,596
| +5% | +$46.7M |
|
42
Union Pacific
UNP
$172B
| $1.02B | 0.64% |
4,615,365
+157,565
| +4% | +$35.1M |
|
43
NVIDIA
NVDA
$4.72T
| $972M | 0.61% |
48,596,840
+1,047,960
| +2% | +$16.8M |
|
44
Thermo Fisher Scientific
TMO
$214B
| $972M | 0.61% |
1,926,422
+112,351
| +6% | +$53M |
|
45
Sanofi
SNY
$103B
| $942M | 0.59% |
17,885,092
-247,533
| -1% | -$12.9M |
|
46
Advanced Micro Devices
AMD
$791B
| $941M | 0.59% |
10,021,656
+495,259
| +5% | +$40M |
|
47
Abbott
ABT
$183B
| $939M | 0.59% |
8,101,764
+318,244
| +4% | +$37.1M |
|
48
Novartis
NVS
$301B
| $909M | 0.57% |
9,962,426
+304,823
| +3% | +$27.1M |
|
49
Morgan Stanley
MS
$330B
| $893M | 0.56% |
9,742,297
+235,518
| +2% | +$20.2M |
|
50
Danaher
DHR
$138B
| $892M | 0.56% |
3,750,386
+128,910
| +4% | +$28.6M |
|
Similar funds
Ken Fisher's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Fisher held 1,100 positions worth $159B, up 12% from $142B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ken Fisher deployed $4.92B of net new capital in Q2 2021, opening 101 new positions and adding to 388 existing holdings. Its largest new stake was Organon & Co: 967,460 shares worth $29.3M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was TSMC, an estimated $77.2M trimmed.
- Ken Fisher's largest Q2 2021 buy was Organon & Co: 967,460 shares worth $29.3M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q2 2021, an estimated $558M increase.
- Ken Fisher's biggest Q2 2021 reduction was TSMC, cutting an estimated $77.2M.
- Ken Fisher fully exited Coherent Inc in Q2 2021, selling an estimated $86.3M.
- Ken Fisher's ten largest holdings make up 32% of its $159B portfolio in Q2 2021.
- Ken Fisher opened 101 new positions and closed 90 in Q2 2021.
- Ken Fisher's portfolio value rose 12% quarter-over-quarter to $159B.
Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.